1-{3-[6-(1-Hydroxy-1-methyl-ethyl)-1-oxy-pyridin-3-yl]-phenyl}-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid cyclopropylamide

ID: ALA485620

PubChem CID: 10297996

Max Phase: Preclinical

Molecular Formula: C26H24N4O4

Molecular Weight: 456.50

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(O)c1ccc(-c2cccc(-n3cc(C(=O)NC4CC4)c(=O)c4cccnc43)c2)c[n+]1[O-]

Standard InChI:  InChI=1S/C26H24N4O4/c1-26(2,33)22-11-8-17(14-30(22)34)16-5-3-6-19(13-16)29-15-21(25(32)28-18-9-10-18)23(31)20-7-4-12-27-24(20)29/h3-8,11-15,18,33H,9-10H2,1-2H3,(H,28,32)

Standard InChI Key:  GVABMKVKGRIEOY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -1.0630   -2.2279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0630   -3.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3485   -3.4654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3485   -1.8154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3660   -2.2279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3660   -3.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0804   -3.4654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7949   -3.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7949   -2.2279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0804   -1.8154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0804   -0.9904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0804   -4.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3660   -4.7029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3660   -5.5279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0804   -5.9404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7949   -5.5279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7949   -4.7029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5094   -1.8154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2238   -2.2279    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5094   -5.9404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2238   -5.5279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9383   -5.9404    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9383   -6.7654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2238   -7.1779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5094   -6.7654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5094   -0.9904    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2238   -0.5779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0488   -0.5779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6363    0.1366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6528   -7.1779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3673   -7.5904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2403   -7.8923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0653   -6.4634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6528   -5.5279    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 16 17  2  0
 17 12  1  0
  7 12  1  0
  5  4  2  0
  9 18  1  0
  8  9  2  0
 18 19  2  0
  4  1  1  0
  9 10  1  0
 20 21  2  0
 10  5  1  0
 21 22  1  0
 22 23  2  0
 10 11  2  0
 23 24  1  0
  2  3  1  0
 24 25  2  0
 25 20  1  0
 16 20  1  0
  5  6  1  0
 18 26  1  0
 12 13  2  0
 26 27  1  0
 28 27  1  0
 29 28  1  0
 27 29  1  0
  3  6  2  0
 13 14  1  0
  6  7  1  0
 23 30  1  0
 14 15  2  0
 30 31  1  0
  1  2  2  0
 30 32  1  0
 15 16  1  0
 30 33  1  0
  7  8  1  0
 22 34  1  0
M  CHG  2  22   1  34  -1
M  END

Associated Targets(Human)

PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Blood (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Squirrel monkey (98 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovis aries (854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.50Molecular Weight (Monoisotopic): 456.1798AlogP: 2.81#Rotatable Bonds: 5
Polar Surface Area: 111.16Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.87CX Basic pKa: 1.86CX LogP: 1.87CX LogD: 1.87
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: -0.94

References

1. Guay D, Boulet L, Friesen RW, Girard M, Hamel P, Huang Z, Laliberté F, Laliberté S, Mancini JA, Muise E, Pon D, Styhler A..  (2008)  Optimization and structure-activity relationship of a series of 1-phenyl-1,8-naphthyridin-4-one-3-carboxamides: identification of MK-0873, a potent and effective PDE4 inhibitor.,  18  (20): [PMID:18835163] [10.1016/j.bmcl.2008.09.009]

Source